Cell Expansion Market (By Product: Consumables, Culture Flasks and Accessories, Instruments; By Cell Type: Mammalian, Animal, Others; By Application: Biopharmaceuticals, Tissue Culture & Engineering, Vaccine Production, Drug Development, Gene Therapy, Cancer Research, Stem Cell Research, Others; By End-Use: Biopharmaceutical & Biotechnology Companies, Research Institutes, Cell Banks, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Cell Expansion Market
5.1. COVID-19 Landscape: Cell Expansion Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Cell Expansion Market, By Product
8.1. Cell Expansion Market, by Product, 2024-2033
8.1.1. Consumables
8.1.1.1. Market Revenue and Forecast (2021-2033)
8.1.2. Culture Flasks and Accessories
8.1.2.1. Market Revenue and Forecast (2021-2033)
8.1.3. Instruments
8.1.3.1. Market Revenue and Forecast (2021-2033)
Chapter 9. Global Cell Expansion Market, By Cell Type
9.1. Cell Expansion Market, by Cell Type, 2024-2033
9.1.1. Mammalian
9.1.1.1. Market Revenue and Forecast (2021-2033)
9.1.2. Animal
9.1.2.1. Market Revenue and Forecast (2021-2033)
9.1.3. Others
9.1.3.1. Market Revenue and Forecast (2021-2033)
Chapter 10. Global Cell Expansion Market, By Application
10.1. Cell Expansion Market, by March, 2024-2033
10.1.1. Biopharmaceuticals
10.1.1.1. Market Revenue and Forecast (2021-2033)
10.1.2. Tissue Culture & Engineering
10.1.2.1. Market Revenue and Forecast (2021-2033)
10.1.3. Vaccine Production
10.1.3.1. Market Revenue and Forecast (2021-2033)
10.1.4. Drug Development
10.1.4.1. Market Revenue and Forecast (2021-2033)
10.1.5. Gene Therapy
10.1.5.1. Market Revenue and Forecast (2021-2033)
10.1.6. Cancer Research
10.1.6.1. Market Revenue and Forecast (2021-2033)
10.1.7. Stem Cell Research
10.1.7.1. Market Revenue and Forecast (2021-2033)
10.1.8. Others
10.1.8.1. Market Revenue and Forecast (2021-2033)
Chapter 11. Global Cell Expansion Market, By End-Use
11.1. Cell Expansion Market, by End-Use, 2024-2033
11.1.1. Biopharmaceutical & Biotechnology Companies
11.1.1.1. Market Revenue and Forecast (2021-2033)
11.1.2. Research Institutes
11.1.2.1. Market Revenue and Forecast (2021-2033)
11.1.3. Cell Banks
11.1.3.1. Market Revenue and Forecast (2021-2033)
11.1.4. Others
11.1.4.1. Market Revenue and Forecast (2021-2033)
Chapter 12. Global Cell Expansion Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Product (2021-2033)
12.1.2. Market Revenue and Forecast, by Cell Type (2021-2033)
12.1.3. Market Revenue and Forecast, by Application(2021-2033)
12.1.4. Market Revenue and Forecast, by End-Use (2021-2033)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Product (2021-2033)
12.1.5.2. Market Revenue and Forecast, by Cell Type (2021-2033)
12.1.5.3. Market Revenue and Forecast, by Application(2021-2033)
12.1.5.4. Market Revenue and Forecast, by End-Use (2021-2033)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Product (2021-2033)
12.1.6.2. Market Revenue and Forecast, by Cell Type (2021-2033)
12.1.6.3. Market Revenue and Forecast, by Application(2021-2033)
12.1.6.4. Market Revenue and Forecast, by End-Use (2021-2033)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Product (2021-2033)
12.2.2. Market Revenue and Forecast, by Cell Type (2021-2033)
12.2.3. Market Revenue and Forecast, by Application(2021-2033)
12.2.4. Market Revenue and Forecast, by End-Use (2021-2033)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Product (2021-2033)
12.2.5.2. Market Revenue and Forecast, by Cell Type (2021-2033)
12.2.5.3. Market Revenue and Forecast, by Application(2021-2033)
12.2.5.4. Market Revenue and Forecast, by End-Use (2021-2033)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Product (2021-2033)
12.2.6.2. Market Revenue and Forecast, by Cell Type (2021-2033)
12.2.6.3. Market Revenue and Forecast, by Application(2021-2033)
12.2.6.4. Market Revenue and Forecast, by End-Use (2021-2033)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Product (2021-2033)
12.2.7.2. Market Revenue and Forecast, by Cell Type (2021-2033)
12.2.7.3. Market Revenue and Forecast, by Application(2021-2033)
12.2.7.4. Market Revenue and Forecast, by End-Use (2021-2033)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Product (2021-2033)
12.2.8.2. Market Revenue and Forecast, by Cell Type (2021-2033)
12.2.8.3. Market Revenue and Forecast, by Application(2021-2033)
12.2.8.4. Market Revenue and Forecast, by End-Use (2021-2033)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Product (2021-2033)
12.3.2. Market Revenue and Forecast, by Cell Type (2021-2033)
12.3.3. Market Revenue and Forecast, by Application(2021-2033)
12.3.4. Market Revenue and Forecast, by End-Use (2021-2033)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Product (2021-2033)
12.3.5.2. Market Revenue and Forecast, by Cell Type (2021-2033)
12.3.5.3. Market Revenue and Forecast, by Application(2021-2033)
12.3.5.4. Market Revenue and Forecast, by End-Use (2021-2033)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Product (2021-2033)
12.3.6.2. Market Revenue and Forecast, by Cell Type (2021-2033)
12.3.6.3. Market Revenue and Forecast, by Application(2021-2033)
12.3.6.4. Market Revenue and Forecast, by End-Use (2021-2033)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Product (2021-2033)
12.3.7.2. Market Revenue and Forecast, by Cell Type (2021-2033)
12.3.7.3. Market Revenue and Forecast, by Application(2021-2033)
12.3.7.4. Market Revenue and Forecast, by End-Use (2021-2033)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Product (2021-2033)
12.3.8.2. Market Revenue and Forecast, by Cell Type (2021-2033)
12.3.8.3. Market Revenue and Forecast, by Application(2021-2033)
12.3.8.4. Market Revenue and Forecast, by End-Use (2021-2033)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Product (2021-2033)
12.4.2. Market Revenue and Forecast, by Cell Type (2021-2033)
12.4.3. Market Revenue and Forecast, by Application(2021-2033)
12.4.4. Market Revenue and Forecast, by End-Use (2021-2033)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Product (2021-2033)
12.4.5.2. Market Revenue and Forecast, by Cell Type (2021-2033)
12.4.5.3. Market Revenue and Forecast, by Application(2021-2033)
12.4.5.4. Market Revenue and Forecast, by End-Use (2021-2033)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Product (2021-2033)
12.4.6.2. Market Revenue and Forecast, by Cell Type (2021-2033)
12.4.6.3. Market Revenue and Forecast, by Application(2021-2033)
12.4.6.4. Market Revenue and Forecast, by End-Use (2021-2033)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Product (2021-2033)
12.4.7.2. Market Revenue and Forecast, by Cell Type (2021-2033)
12.4.7.3. Market Revenue and Forecast, by Application(2021-2033)
12.4.7.4. Market Revenue and Forecast, by End-Use (2021-2033)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Product (2021-2033)
12.4.8.2. Market Revenue and Forecast, by Cell Type (2021-2033)
12.4.8.3. Market Revenue and Forecast, by Application(2021-2033)
12.4.8.4. Market Revenue and Forecast, by End-Use (2021-2033)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Product (2021-2033)
12.5.2. Market Revenue and Forecast, by Cell Type (2021-2033)
12.5.3. Market Revenue and Forecast, by Application(2021-2033)
12.5.4. Market Revenue and Forecast, by End-Use (2021-2033)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Product (2021-2033)
12.5.5.2. Market Revenue and Forecast, by Cell Type (2021-2033)
12.5.5.3. Market Revenue and Forecast, by Application(2021-2033)
12.5.5.4. Market Revenue and Forecast, by End-Use (2021-2033)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Product (2021-2033)
12.5.6.2. Market Revenue and Forecast, by Cell Type (2021-2033)
12.5.6.3. Market Revenue and Forecast, by Application(2021-2033)
12.5.6.4. Market Revenue and Forecast, by End-Use (2021-2033)
Chapter 13. Company Profiles
13.1. Thermo Fisher Scientific, Inc.
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. GE Healthcare
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Corning, Inc.
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. STEMCELL Technologies, Inc.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Merck KGaA
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Miltenyi Biotec
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Becton, Dickinson and Company
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Terumo Bct, Inc.
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Sartorius AG
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Takara Bio, Inc.
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client